Exelixis Inc (NASDAQ: EXEL) flaunted slowness of -1.77% at $28.32, before settling in for the price of $28.83 at the close. Taking a more long-term approach, EXEL posted a 52-week range of $18.64-$29.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 17.31%. Meanwhile, its Annual Earning per share during the time was -21.77%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 139.04%. This publicly-traded company’s shares outstanding now amounts to $302.79 million, simultaneously with a float of $277.90 million. The organization now has a market capitalization sitting at $8.08 billion.
Exelixis Inc (EXEL) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Exelixis Inc industry. Exelixis Inc’s current insider ownership accounts for 2.58%, in contrast to 86.03% institutional ownership. According to the most recent insider trade that took place on Sep 23 ’24, this organization’s EVP & General Counsel sold 25,000 shares at the rate of 26.38, making the entire transaction reach 659,500 in total value, affecting insider ownership by 605,325.
Exelixis Inc (EXEL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.33 per share during the current fiscal year.
Exelixis Inc’s EPS increase for this current 12-month fiscal period is 139.04% and is forecasted to reach 1.48 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 29.92% through the next 5 years, which can be compared against the -21.77% growth it accomplished over the previous five years trading on the market.
Exelixis Inc (NASDAQ: EXEL) Trading Performance Indicators
Let’s observe the current performance indicators for Exelixis Inc (EXEL). It’s Quick Ratio in the last reported quarter now stands at 4.21. The Stock has managed to achieve an average true range (ATR) of 0.74. Alongside those numbers, its PE Ratio stands at $24.25, and its Beta score is 0.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.01. Similarly, its price to free cash flow for trailing twelve months is now 29.11.
In the same vein, EXEL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.17, a figure that is expected to reach 0.34 in the next quarter, and analysts are predicting that it will be 1.48 at the market close of one year from today.
